Intracellular concentration of Antiretrovirals (INCA STUDY).

Trial Profile

Intracellular concentration of Antiretrovirals (INCA STUDY).

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Sep 2012

At a glance

  • Drugs Atazanavir (Primary) ; Efavirenz (Primary) ; Ritonavir (Primary) ; Emtricitabine/tenofovir disoproxil fumarate
  • Indications HIV infections
  • Focus Pharmacokinetics
  • Acronyms INCA
  • Most Recent Events

    • 16 Mar 2012 Actual end date (27 May 2009) added as reported by European Clinical Trials Database.
    • 08 Mar 2012 Lipid and lipoprotein substudy results presented at the 19th Conference on Retroviruses and Opportunistic Infections.
    • 19 Oct 2011 An analysis of whether the combination of TDF and ATV/r is associated with a different evolution of eGFR in comparison to TDF and EFV, when it is estimated by CKD-EPI creatinine or CKD-EPI cystatin C equations, has been published in JAIDS.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top